Results 51 to 60 of about 47,842 (168)

Targeting Cystine Metabolism in the Lung Cancer Environment Enhances the Efficacy of Immune Checkpoint Inhibition

Advanced Science
Immunotherapy with Immune Checkpoint Inhibitors (ICIs) has shown promising therapeutic effects in the treatment of lung cancer, the overall efficacy of PD‐1/PD‐L1 inhibitors is only 20%‐30%. Thus, more effective combination therapies are needed.
Yun Xu, Shumin Li, Jiaji Wu, Shumin Xu, Mo Shen, Chenyang Wang, Andreas Lundqvist, Jianghao Yu, Zhiyong Xu, Yueli Shi, Nana Liu, Yunke Yang, Jiangnan Zhao, Ying Yang, Pingli Wang, Peng Yi, Jin Cheng, Junhui Sun, Mengshu Li, Peng Xiao, Kai Wang   +20 more
doaj   +1 more source

Ocular cystinosis: Rarity redefined

Indian Journal of Ophthalmology, 2019
Mayuresh P Naik, Harinder S Sethi, Smriti Dabas   +2 more
doaj   +1 more source

The First Cystine Stone? [PDF]

BMJ, 1964
P D, GRIFFITHS, R G, HUNTSMAN, C G, THOMAS   +2 more
openaire   +2 more sources

On the Determination and Preparation of Cystine [PDF]

Bulletin of the Agricultural Chemical Society of Japan, 1929
OKUKA, Y., KOBAYASHI, T.
openaire   +1 more source

Cystine and nephrotoxicity [PDF]

Biochemical Journal, 1933
openaire   +2 more sources

Cystine [PDF]

, 2020
openaire   +1 more source

GENDER AND AGE DISTRIBUTION AND CHEMICAL COMPOSITION OF RENAL STONES

Gomal Journal of Medical Sciences, 2014
Background: Renal stones are commonest urological disease worldwide. The objective of this study was to analyze the chemical composition of renal stones in relation to gender and age in District Dera Ismail Khan and its adjacent areas, Pakistan ...
Ghazi Khan, Sajjad Ahmad, Sadia Anwar, Muhammad Marwat   +3 more
doaj  

Targeting Cystine Addiction Suppresses Breast Cancer Lung Metastasis. [PDF]

Cancer Res
Tarragó-Celada J, Mahmood AS, Panina Y, Lalwani S, Atkinson S, Spicer A, Kossifos M, Cai W, Gjelaj E, Venkateswaran SV, Sesay S, Furlani I, Legrave NM, Gilmore T, Mitter R, Bordoloi J, Ghanate A, Wu V, Takáts Z, Yan B, Dexter A, Steven RT, Bunch J, Georgiou G, Stone EM, Tarrado-Castellarnau M, MacRae JI, Burt RJ, Yuneva M.   +28 more
europepmc   +1 more source

Cystine: A Key Protective Factor Against Childhood Hypo-HDL Cholesterolemia and Dyslipidemia-A Matched Case-Control Study. [PDF]

Nutrients
Yu L, Yue Q, Zhu Q, Liu Y, Tian M, Liu C, Tang Z.   +6 more
europepmc   +1 more source

An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients

Clinical Ophthalmology
Nobuhiro Goi,1 Fumino Iwata,2 Yoko Sugihara,3 Shingo Higa,1 Taiichiro Chikama4 1Medical Affairs, Viatris Pharmaceuticals Japan G.K., Tokyo, Japan; 2Iwata Eye Clinic, 2-15-21 Nishinakanobu, Shinagawa-ku, Tokyo, 142-0054, Japan; 3Global Clinical Operations,
Goi N, Iwata F, Sugihara Y, Higa S, Chikama T   +4 more
doaj